Quinoline-4-methyl esters as human nonpancreatic secretory phospholipase A2 inhibitors-Science-Chemical Encyclopedia-lookchem

Quinoline-4-methyl esters as human nonpancreatic secretory phospholipase A2 inhibitors
Add time:08/23/2019 Source:sciencedirect.com

A series of novel fused heterocycle methyl esters were designed and synthesized as human nonpancreatic secretory phospholipase A2 (hnps-PLA2) competitive inhibitors. Among the 22 synthesized compounds, 17 quinoline-4-methyl esters displayed hnps-PLA2 inhibition activity in the in vitro bioassay. The IC50 value for the best compound 3o was 1.5 μM. The structure-inhibition–activity relationships of the compounds were studied using molecular docking.

We also recommend Trading Suppliers and Manufacturers of 4-(2-CHLORO-PHENYL)-3-OXO-BUTYRIC ACID METHYL ESTER (cas 116921-39-2). Pls Click Website Link as below: cas 116921-39-2 suppliers

Prev:Photosynthesis—Inhibiting efficiency of 4-chloro-2-(chlorophenylcarbamoyl)phenyl alkylcarbamates
Next: Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2′,3′:3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor)

Click to view details

Encyclopedia